Transgenic Group (TSE:2342) Construction In Progress: 円0 Mil (As of Mar. 2026)


TSE:2342 Transgenic Group Inc TSE:2342
58 GF Score
Price 円212.00
GF Value 円257.39
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Transgenic Group Construction In Progress?

Transgenic Group TSE:2342 +1.44% 58 Construction In Progress is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:2342 with a GF Score™ of 58/100 and a GF Value™ of 円257.39 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Transgenic Group's annual construction in progress declined from Mar. 2024 (円19 Mil) to Mar. 2025 (円0 Mil) but then stayed the same from Mar. 2025 (円0 Mil) to Mar. 2026 (円0 Mil).

Transgenic Group Construction In Progress Historical Data

* Premium members only.

The historical data trend for Transgenic Group's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transgenic Group Construction In Progress Chart

Transgenic Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 3.79 18.70 0.00 0.00

Transgenic Group Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.70 0.00 0.00 0.00 0.00
TSE:2342
58GF Score
Transgenic Group Inc TSE:2342
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Transgenic Group Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of 円0 Mil mean?
Transgenic Group (TSE:2342) has a Construction In Progress of 円0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Transgenic Group and its competitors.
Is Transgenic Group's Construction In Progress too high?
Transgenic Group's current Construction In Progress is 円0 Mil. Overall, Transgenic Group has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Transgenic Group's Construction In Progress compare to VRTX and REGN?
Transgenic Group's Construction In Progress of 円0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Transgenic Group and its competitors. Transgenic Group's current Construction In Progress is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transgenic Group stock overvalued right now?
Based on GuruFocus' analysis, Transgenic Group (TSE:2342) is currently considered Modestly Undervalued. The stock's GF Value™ is 円257.39, compared to a current price of 円212.00 — trading 17.6% below its estimated fair value. The current Construction In Progress is 円0 Mil. Transgenic Group's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Transgenic Group (TSE:2342), the current Construction In Progress is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Transgenic Group (TSE:2342) Overvalued in 2026?

Based on GuruFocus' analysis, Transgenic Group stock appears to be undervalued. The current stock price of 円212.00 is trading 17.6% below its estimated GF Value™ of 円257.39. GuruFocus considers Transgenic Group to be Modestly Undervalued.

Key valuation signals for TSE:2342:

  • Construction In Progress: 円0 Mil
  • GF Value™: 円257.39 vs. price of 円212.00 (17.6% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the TSE:2342 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Transgenic Group Business Description

Address 2-3-36 Tenjin, Chuo-ku, Fukuoka Prefecture, Fukuoka, JPN
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.
58GF Score

Get the complete analysis for TSE:2342

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円212.00
Price
円257.39
GF Value